DSS INC (DSS)

AMEXConsumer DiscretionaryPackaging & ContainersSnapshot 2026-10-23

$0.51-5.38%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge DSS INC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	5.3M
EPS	—	-0.21
Annual ending 2026-12-31
Revenue	—	19.53M
EPS	—	-1.38

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Secure and maintain financing of at least $2.45 million	This capital supports operations despite a $5.8 million loss in Q1 2026.	Intact	financing secured falls below $2,450,000 or agreements are lost	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 2 quarters. DSS secured $2.45M in 2026-Q1 and $1.0M in 2026-Q2 through convertible promissory notes and warrants with Alset entities. This shows active delivery on financing commitments in 2026. Delivery assessment Oct 24, 2026
Address ongoing litigation issues effectively	A primary condition in DSS INC's published investment case. The stated target is progress in resolving litigation issues.	Intact	litigation issues escalate or cause material financial impact	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Stabilize revenue near $5.3 million next quarter	Analysts expect revenue of $5.3 million next quarter, showing some operational continuity.	Broken	revenue falls below $5.3 million next quarter	Revenue: $3.604M FY2026-Q2; GAAP. Published target: >= $5.3 million revenue. The stored target says 2026-Q3; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 14, 20263,604,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: ae1d1301-7d85-4eac-b023-8ca50cd6b349. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · alphavantage

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · alphavantage
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-06-15	Unavailable	Unavailable	— / 0
2026-06-20	Unavailable	Unavailable	— / 0
2026-06-23	Unavailable	Unavailable	— / 0
2026-06-24	Unavailable	Unavailable	— / 0
2026-06-25	Unavailable	Unavailable	— / 0
2026-06-27	Unavailable	Unavailable	— / 0
2026-06-28	Unavailable	Unavailable	— / 0
2026-06-29	Unavailable	Unavailable	— / 0
2026-06-30	Unavailable	Unavailable	— / 0
2026-07-01	Unavailable	Unavailable	— / 0
2026-07-02	Unavailable	Unavailable	— / 0
2026-07-04	Unavailable	Unavailable	— / 0
2026-07-05	Unavailable	Unavailable	— / 0
2026-07-06	Unavailable	Unavailable	— / 0
2026-07-07	Unavailable	Unavailable	— / 0
2026-07-30	Unavailable	Unavailable	— / 0
2026-07-31	Unavailable	Unavailable	— / 0
2026-08-02	Unavailable	Unavailable	— / 0
2026-08-08	Unavailable	Unavailable	— / 0
2026-08-09	Unavailable	Unavailable	— / 0
2026-08-11	Unavailable	Unavailable	— / 0
2026-08-12	Unavailable	Unavailable	— / 0
2026-08-15	Unavailable	Unavailable	— / 0
2026-08-16	Unavailable	Unavailable	— / 0
2026-08-17	Unavailable	Unavailable	— / 0
2026-08-18	Unavailable	Unavailable	— / 0
2026-08-19	Unavailable	Unavailable	— / 0
2026-08-20	Unavailable	Unavailable	— / 0
2026-08-21	Unavailable	Unavailable	— / 0
2026-08-22	Unavailable	Unavailable	— / 0
2026-08-23	Unavailable	Unavailable	— / 0
2026-08-24	Unavailable	Unavailable	— / 0
2026-08-25	Unavailable	Unavailable	— / 0
2026-08-26	Unavailable	Unavailable	— / 0
2026-08-27	Unavailable	Unavailable	— / 0
2026-08-28	Unavailable	Unavailable	— / 0
2026-08-29	Unavailable	Unavailable	— / 0
2026-08-30	Unavailable	Unavailable	— / 0
2026-08-31	Unavailable	Unavailable	— / 0
2026-09-01	Unavailable	Unavailable	— / 0
2026-09-02	Unavailable	Unavailable	— / 0
2026-09-03	Unavailable	Unavailable	— / 0
2026-09-04	Unavailable	Unavailable	— / 0
2026-09-05	Unavailable	Unavailable	— / 0
2026-09-06	Unavailable	Unavailable	— / 0
2026-09-07	Unavailable	Unavailable	— / 0
2026-09-08	Unavailable	Unavailable	— / 0
2026-09-09	Unavailable	Unavailable	— / 0
2026-09-10	Unavailable	Unavailable	— / 0
2026-09-11	Unavailable	Unavailable	— / 0
2026-09-12	Unavailable	Unavailable	— / 0
2026-09-13	Unavailable	Unavailable	— / 0
2026-09-14	Unavailable	Unavailable	— / 0
2026-09-15	Unavailable	Unavailable	— / 0
2026-09-16	Unavailable	Unavailable	— / 0
2026-09-17	Unavailable	Unavailable	— / 0
2026-09-18	Unavailable	Unavailable	— / 0
2026-09-19	Unavailable	Unavailable	— / 0
2026-09-20	Unavailable	Unavailable	— / 0
2026-09-21	Unavailable	Unavailable	— / 0
2026-09-22	Unavailable	Unavailable	— / 0
2026-09-23	Unavailable	Unavailable	— / 0
2026-09-24	Unavailable	Unavailable	— / 0
2026-09-25	Unavailable	Unavailable	— / 0
2026-09-26	Unavailable	Unavailable	— / 0

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	1	0	0
2026-06-01	1	0	0
2026-07-01	1	0	0
2026-08-01	1	0	0
2026-09-01	1	0	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Secure and maintain financing of at least $2.45 millionDirect metric needs a verified mapping
Address ongoing litigation issues effectivelyDirect metric needs a verified mapping
Stabilize revenue near $5.3 million next quarterPublished status: Broken

Next proof point

Nov 13, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

2.6%Typical daily move · historical

Downside history

-69.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

DSS INC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a speculative, high-risk business rather than a proven durable compounder, with weak recent financial performance and loss-making earnings. The multi-year view is on watch because performance remains well below its industry cohort, though the evidence does not show a fresh break in the thesis.

What's priced into DSS INC

The valuation signal points to DSS being cheap versus peers, but confidence in that comparison is low. The expectations gap is slightly negative, and the priced-in assessment is tagged justified with no fragility gates triggered, so the evidence does not point to a clear mismatch between market expectations and the business setup.

What the fundamentals likely do

Near term, financing activity has continued through agreements with Alset entities, while management's financing priority is rated mixed and litigation remains a watch item. Recent financial performance is weak, earnings are loss-making, and the estimated chance of a miss next period is elevated at 48%; measured stock and market risk have both fallen, but remain high overall.

What DSS INC hinges on

Over the next few quarters, sector bellwethers TRS, MYE, and KRT could signal whether Consumer Discretionary momentum is strengthening or fading. A material slowdown in GDP growth from 2.2%, especially below 2%, would be a sector-specific concern; the multi-year thesis also depends on improved financial performance and progress on financing and litigation.